CN112457368A - 药学相关的芳香族阳离子肽 - Google Patents

药学相关的芳香族阳离子肽 Download PDF

Info

Publication number
CN112457368A
CN112457368A CN202011243175.7A CN202011243175A CN112457368A CN 112457368 A CN112457368 A CN 112457368A CN 202011243175 A CN202011243175 A CN 202011243175A CN 112457368 A CN112457368 A CN 112457368A
Authority
CN
China
Prior art keywords
acid
compound
hydrogen
formula
hexafluorophosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011243175.7A
Other languages
English (en)
Chinese (zh)
Inventor
D·特拉维斯·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kant Biomedical Co ltd
Original Assignee
Stealth Biotherapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Corp filed Critical Stealth Biotherapeutics Corp
Publication of CN112457368A publication Critical patent/CN112457368A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202011243175.7A 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽 Pending CN112457368A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361921376P 2013-12-27 2013-12-27
US61/921,376 2013-12-27
US201461947261P 2014-03-03 2014-03-03
US61/947,261 2014-03-03
CN201480075290.4A CN106132984B (zh) 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201480075290.4A Division CN106132984B (zh) 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽

Publications (1)

Publication Number Publication Date
CN112457368A true CN112457368A (zh) 2021-03-09

Family

ID=53479676

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480075290.4A Active CN106132984B (zh) 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽
CN202011243175.7A Pending CN112457368A (zh) 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201480075290.4A Active CN106132984B (zh) 2013-12-27 2014-12-23 药学相关的芳香族阳离子肽

Country Status (6)

Country Link
US (2) US10221213B2 (enExample)
EP (1) EP3087093B1 (enExample)
JP (1) JP6626446B2 (enExample)
CN (2) CN106132984B (enExample)
CA (1) CA2935207C (enExample)
WO (1) WO2015100376A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100376A1 (en) * 2013-12-27 2015-07-02 Stealth Peptides International, Inc. Pharmaceutically relevant aromatic-cationic peptides
HUE054626T2 (hu) * 2014-06-25 2021-09-28 Flamma Spa Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására
US10112976B2 (en) 2014-06-30 2018-10-30 Flamma S.P.A. Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
EP3800192A1 (en) * 2015-03-06 2021-04-07 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
AU2017249218B2 (en) 2016-04-11 2020-08-27 Arcuate Therapeutics, Inc. Chiral peptides
US10961273B2 (en) 2016-08-16 2021-03-30 Stealth Biotherapeutics Corp. N-carboxyanhydride-based-scale synthesis of elamipretide
WO2018187400A1 (en) 2017-04-05 2018-10-11 Stealth Biotherapeutics Corp. Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
CN108929371A (zh) * 2018-08-02 2018-12-04 哈尔滨师范大学 一种Phakellistatin13直链衍生物、其制备办法及用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174117A2 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN106132984A (zh) * 2013-12-27 2016-11-16 康德生物医疗技术公司 药学相关的芳香族阳离子肽

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067000C1 (ru) 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6248716B1 (en) * 1995-06-27 2001-06-19 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
WO2002000263A2 (en) 2000-06-14 2002-01-03 Medarex, Inc. Tripeptide prodrug compounds
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
WO2011116007A1 (en) * 2010-03-15 2011-09-22 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
HK1204988A1 (en) 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP3459598A1 (en) 2012-12-06 2019-03-27 Stealth Peptides International, Inc. Combinations of peptide therapeutics and methods for using same
WO2015060462A1 (en) 2013-10-23 2015-04-30 Kaneka Corporation Tetrapeptide compound and method for producing same
WO2015134096A1 (en) 2014-03-03 2015-09-11 Stealth Peptides International, Inc. Pharmaceutically relevant aromatic-cationic peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174117A2 (en) * 2011-06-14 2012-12-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN106132984A (zh) * 2013-12-27 2016-11-16 康德生物医疗技术公司 药学相关的芳香族阳离子肽

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YUKO TSUDA ET AL.: "Amino acid Coupling Chemistry,Solution-Phase peptide synthesis", 《AMINO ACID,PEPTIDE AND PROTEINS IN ORGANIC CHEMISTRY》, pages 203 - 234 *

Also Published As

Publication number Publication date
CA2935207A1 (en) 2015-07-02
US20200024308A1 (en) 2020-01-23
EP3087093A4 (en) 2017-09-27
EP3087093A1 (en) 2016-11-02
JP2017502956A (ja) 2017-01-26
CA2935207C (en) 2022-06-21
CN106132984A (zh) 2016-11-16
EP3087093B1 (en) 2021-11-10
JP6626446B2 (ja) 2019-12-25
US10221213B2 (en) 2019-03-05
US20160340389A1 (en) 2016-11-24
CN106132984B (zh) 2020-12-08
US10696716B2 (en) 2020-06-30
WO2015100376A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
CN112457368A (zh) 药学相关的芳香族阳离子肽
CN107530395B (zh) 制备药物相关肽的方法
CN106459169A (zh) 药学上相关的芳香族阳离子肽
ES2730474T3 (es) Proceso para la preparación de ivacaftor y solvatos de este
CA2801101A1 (en) Process for preparing a biphenyl-2-ylcarbamic acid
Feher et al. Octafunctionalized polyhedral oligosilsesquioxanes as scaffolds: Synthesis of peptidyl silsesquioxanes
HK1230631B (en) Pharmaceutically relevant aromatic-cationic peptides
HK40049251A (en) Processes for preparing pharmaceutically relevant peptides
HK1248604B (en) Processes for preparing pharmaceutically relevant peptides
HK1248604A1 (en) Processes for preparing pharmaceutically relevant peptides
KR20030033001A (ko) 5-페닐펜타노일-ala-argl-ala-[2-(3-아미노-2-옥소피롤리딘-1-일)프로피오닐]-ala-arg-ala-4-아미노페닐아세트아미드의 제조방법
CN111943894A (zh) 一种4,7-二氮杂螺[2.5]辛烷类化合物的合成方法
WO2013140331A1 (en) New 1, 2, 4-oxadiazol derivatives, process for their preparation and use thereof as intermediates in the preparation of indolic alkaloids

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220627

Address after: Massachusetts, USA

Applicant after: Kant biomedical Co.,Ltd.

Address before: Monaco City, Monaco

Applicant before: STEALTH PEPTIDES INTERNATIONAL, Inc.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210309